Neurol. praxi. 2022;23(4):273-277

Malformations of cortical development and their epilepsy surgery

MUDr. Martin Kudr, Ph.D.1, MUDr. Martin Kynčl, Ph.D.2, prof. MUDr. Pavel Kršek, Ph.D.1
1 Klinika dětské neurologie 2. LF UK a FN Motol, Praha
2 Klinika zobrazovacích metod 2. LF UK a FN Motol, Praha

Congenital malformations of cortical development (MCD) are frequent underlying pathology of focal structural epilepsies in children as well as adults. MCDs form a broad group of disorders ranging from well-localized lesions in focal cortical dysplasia (FCD) type II, through lobar and multilobar involvement in FCD types I and II, to extensive malformations affecting one or both hemispheres (hemimegalencephaly, lissencephaly). Pharmacoresistance, which is defined as the failure of two adequately selected anti-seizure drugs at the maximum tolerated doses, is reported in 65% of patients with MCD. For many patients with MCD epilepsy surgery is the only option for successful treatment. This manuscript presents MCDs that can be treated by epilepsy surgery.

Keywords: epilepsy, epilepsy surgery, malformations of cortical development (MCD), focal cortical dysplasias (FCD).

Received: January 16, 2022; Revised: March 25, 2022; Accepted: March 25, 2022; Prepublished online: March 25, 2022; Published: August 30, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kudr M, Kynčl M, Kršek P. Malformations of cortical development and their epilepsy surgery. Neurol. praxi. 2022;23(4):273-277.
Download citation

References

  1. Arzimanoglou A, Cross JH, Gaillard WD, et al. Pediatric Epilepsy Surgery. John Libbey Eurotext Limited Gazelle Book Services Limited [distributor, Montrouge; Lancaster. 2017.
  2. Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1. Epilepsia. 2011;52:158-174. Go to original source... Go to PubMed...
  3. Brázdil M, Hadac J, Marusic P. Farmakorezistentní epilepsie. Triton, 2011. V Praze.
  4. Chassoux F, Landre E, Rodrigo S, et al. Intralesional recordings and epileptogenic zone in focal polymicrogyria. Epilepsia. 2008;49:51-64. Go to original source... Go to PubMed...
  5. Coras R, Holthausen H, Sarnat HB. Focal cortical dysplasia type 1. Brain Pathol. 2021;31. Go to original source... Go to PubMed...
  6. Eltze CM, Landre E, Soufflet C, Chassoux F. Sleep related epilepsy in focal cortical dysplasia type 2: Insights from sleep recordings in presurgical evaluation. Clin. Neurophysiol. 2020;131:609-615. Go to original source... Go to PubMed...
  7. Guerrini R, Duchowny M, Jayakar P, et al. Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015;56:1669-1686. Go to original source... Go to PubMed...
  8. Holthausen H, Coras R, Tang Y, et al. Multilobar unilateral hypoplasia with emphasis on the posterior quadrant and severe epilepsy in children with FCD ILAE Type 1 A. Epilepsia. 2022;63:42-60. Go to original source... Go to PubMed...
  9. Holthausen H, Pieper T, Winkler P, Bluemcke I, Kudernatsch M. Electro­‑clinical­‑pathological correlations in focal cortical dysplasia (FCD) at young ages. Childs Nerv. Syst. 2014;30:2015-2026. Go to original source... Go to PubMed...
  10. Krsek P, Kudr M, Jahodova A, et al. Localizing value of ictal SPECT is comparable to MRI and EEG in children with focal cortical dysplasia. Epilepsia. 2013;54:351-358. Go to original source... Go to PubMed...
  11. Krsek P, Maton B, Korman B, et al. Different features of histopathological subtypes of pediatric focal cortical dysplasia. Ann. Neurol. 2008;63:758-769. Go to original source... Go to PubMed...
  12. Krsek P, Pieper T, Karlmeier A, et al. Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia. 2009;50:125-137. Go to original source... Go to PubMed...
  13. Kudr M, Krsek P, Marusic P, et al. SISCOM and FDG­‑PET in patients with non­‑lesional extratemporal epilepsy: correlation with intracranial EEG, histology, and seizure outcome. Epileptic Disord. Int. Epilepsy J. Videotape. 2013;15:3-13. Go to original source... Go to PubMed...
  14. Kudr M, Krsek P, Maton B, et al. Ictal SPECT is useful in localizing the epileptogenic zone in infants with cortical dysplasia. Epileptic Disord. Int. Epilepsy J. Videotape. 2016;18:384-390. Go to original source... Go to PubMed...
  15. Lamberink HJ, Otte WM, Blümcke I, et al. Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol. 2020;19:748-757. Go to original source... Go to PubMed...
  16. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology. 2004;62:S2-S8. Go to original source... Go to PubMed...
  17. Ramantani G, Koessler L, Colnat­‑Coulbois S, et al. Intracranial evaluation of the epileptogenic zone in regional infrasylvian polymicrogyria: Epileptogenic Zone in Infrasylvian PMG. Epilepsia. 2013;54:296-304. Go to original source... Go to PubMed...
  18. Tassi L. Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain. 2004;128:321-337. Go to original source... Go to PubMed...
  19. Tinkle BT, Schorry EK, Franz DN, Crone KR, Saal HM. Epidemiology of hemimegalencephaly: A case series and review. Am. J. Med. Genet. A. 2005;139 A:204-211. Go to original source... Go to PubMed...
  20. Wang T, Liu Q, Liu M, et al. Clinical features and surgical outcomes in young children with focal cortical dysplasia type II. CNS Neurosci. Ther. 2020;26:270-277. Go to original source... Go to PubMed...
  21. Widdess­‑Walsh P, Diehl B, Najm I. Neuroimaging of focal cortical dysplasia. J. Neuroimaging. 2006;16:185-196. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.